Brief: Aytu Biopharma Inc Qtrly Total Net Revenue Was $30.7 Million, Up 12%

Aytu Biopharma

27/09/2023 23:09

Sept 27 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA INC - QTRLY TOTAL NET REVENUE WAS $30.7
MILLION,
UP 12%
    * AYTU BIOPHARMA INC - QTRLY NET LOSS $0.59 PER SHARE
    * AYTU BIOPHARMA INC - IN JUNE 2023, CO BEGAN THE WIND DOWN
OF ITS
CONSUMER HEALTH SEGMENT
    * AYTU BIOPHARMA: EXPECTS TO SELL THROUGH REMAINING
INVENTORY ON
HAND RESULTING IN NEUTRAL TO MINIMAL ADJUSTED EBITDA FOR
CONSUMER HEALTH SEGMENT IN 2024


Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com;))